A nurse is reviewing the admission prescriptions for a client who has benign prostatic hyperplasia. Which of the following medications should the nurse expect to administer?

Choice A rationale
Urine specific gravity of 1.020 is within the normal range (1.005 to 1.030). This indicates that the urine concentration is normal and does not suggest any abnormality that needs to be reported.
Choice B rationale
Microscopic hematuria refers to the presence of red blood cells in the urine, which is not visible to the naked eye. This finding can indicate a urinary tract infection, kidney stones, or other renal pathology and should be reported to the provider for further evaluation.
Choice C rationale
Amber yellow urine color is considered normal and does not indicate any pathology. The color of urine can vary depending on hydration status and does not necessarily indicate a problem.
Choice D rationale

The absence of glucose in the urine is a normal finding. The presence of glucose in the urine would indicate glycosuria, which is often associated with diabetes mellitus.

Choice A rationale
Regular insulin is correct because it is a short-acting insulin that can be used to treat diabetic ketoacidosis (DKA). The client’s symptoms of confusion, flushed appearance, and acetone odor on the breath suggest DKA, which requires prompt treatment with insulin to lower blood glucose levels and correct metabolic acidosis. Regular insulin has a rapid onset of action and can be administered intravenously to achieve quick results.
Choice B rationale
NPH insulin is incorrect because it is an intermediate-acting insulin that is not suitable for the immediate treatment of DKA. NPH insulin has a slower onset of action and is typically used for

basal insulin coverage rather than for acute management of hyperglycemia. In cases of DKA, rapid-acting or short-acting insulin is preferred to achieve quick glucose control.
Choice C rationale
Glargine insulin is incorrect because it is a long-acting insulin that provides basal insulin coverage over 24 hours. It is not suitable for the immediate treatment of DKA, as it does not have a rapid onset of action. Glargine insulin is typically used for maintaining stable blood glucose levels over a prolonged period rather than for acute management of hyperglycemia.
Choice D rationale
Detemir insulin is incorrect because it is a long-acting insulin similar to glargine. It provides basal insulin coverage and is not suitable for the immediate treatment of DKA. Detemir insulin has a slower onset of action and is used for maintaining stable blood glucose levels rather than for rapid correction of hyperglycemia in acute situations.